Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Infection
Metadata
Title
Antibody Response to Influenza Vaccine in Children with Bronchopulmonary Dysplasia
Author

Publication date
01-06-2001
Publisher
Urban & Vogel Medien und Medizin Verlagsgesellschaft
Published in
Infection / Issue 3/2001
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-001-9075-7

Other articles of this Issue 3/2001

Infection 3/2001 Go to the issue

Clinical and Epidemiological Study

Enterovirus Infections in Germany: Comparative Evaluation of Different Laboratory Diagnostic Methods

Clinical and Epidemiological Study

Nosocomial Kikuchi's Disease – A Search for Herpesvirus Sequences in Lymph Node Tissues Using PCR

Clinical and Epidemiological Study

Chlamydia trachomatis in Andrologic Patients – Direct and Indirect Detection

Correspondence

Crystalloids: An latrogenic Source of Multiple Organ Failure?

Clinical and Epidemiological Study

Clinical Relevance of CagA-specific Antibodies Related to CagA Status of Heliobacter pylori Isolates Using Immunofluorescence Test and PCR

Clinical and Epidemiological Study

Antimicrobial Expenditures and Usage at Four University Hospitals

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits